NCT01130025 2025-02-24
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
LEO Pharma
Phase 3 Completed
Clinical Trials
8 trialsNCT03090880 2022-11-17
PROVE
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated
NCT03099031 2019-12-16
PREDICARE
LEO Pharma
Completed
NCT03240120 2019-04-17
A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
The University of Hong Kong
Phase 3 Unknown
NCT01817257 2018-10-29
ALICAT
Cardiff University
Phase 2 Terminated
NCT00981903 2017-07-06
Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer
University of Southern California
Phase 2 Terminated
NCT01164046 2014-12-03
Longheva
University Medical Center Groningen
Phase 3 Terminated
NCT00629447 2013-01-07
Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients
Duke University
Phase NA Completed